K. R. Machlus and J. E. Italiano, The incredible journey: From megakaryocyte development to platelet formation, J Cell Biol, vol.201, pp.785-796, 2013.

J. E. Italiano, P. Lecine, R. A. Shivdasani, and J. H. Hartwig, Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes, J Cell Biol, vol.147, pp.1299-1312, 1999.

S. Chen, Y. Su, and J. Wang, ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation, Cell Death Dis, vol.4, 2013.

G. P. Fadini, F. Ferraro, F. Quaini, T. Asahara, and P. Madeddu, Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration, Stem Cells Transl Med, vol.3, pp.949-957, 2014.

O. Naveiras, Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment, Nature, vol.460, pp.259-263, 2009.

Y. Song, Y. T. Wang, X. J. Huang, and Y. Kong, Abnormalities of the bone marrow immune microenvironment in patients with immune thrombocytopenia, Ann Hematol, vol.95, pp.959-965, 2016.

H. Vera, R. Vilahur, G. Ferrer-lorente, R. Pena, E. Badimon et al., Platelets derived from the bone marrow of diabetic animals show dysregulated endoplasmic reticulum stress proteins that contribute to increased thrombosis, Arterioscler Thromb Vasc Biol, vol.32, pp.2141-2148, 2012.

P. Ferroni, S. Basili, A. Falco, and G. Davi, Platelet activation in type 2 diabetes mellitus, J Thromb Haemost, vol.2, pp.1282-1291, 2004.

P. J. Grant, Diabetes mellitus as a prothrombotic condition, J Intern Med, vol.262, pp.157-172, 2007.

R. Liani, Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients, Free Radic Biol Med, vol.52, pp.1318-1324, 2012.

P. Soma, A. C. Swanepoel, J. N. Du-plooy, T. Mqoco, and E. Pretorius, Flow cytometric analysis of platelets type 2 diabetes mellitus reveals 'angry' platelets, Cardiovasc Diabetol, vol.15, 2016.

A. J. Gerrits, Induction of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1 and retinol binding protein 4 in human megakaryocytes, Haematologica, vol.97, pp.1149-1157, 2012.

N. Varo, Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products, Diab Vasc Dis Res, vol.2, pp.81-87, 2005.

E. Vericel, C. Januel, M. Carreras, P. Moulin, and M. Lagarde, Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status, Diabetes, vol.53, pp.1046-1051, 2004.

A. J. Barrett, Proteinase Inhibitors, pp.515-569, 1986.

Z. Grzonka, Structural studies of cysteine proteases and their inhibitors, Acta Biochim Pol, vol.48, pp.1-20, 2001.

J. Choi, Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans, Nucleic Acids Res, vol.47, pp.780-785, 2019.

B. R. Huebner, Thrombin Provokes Degranulation of Platelet alpha-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1), Shock, vol.50, pp.671-676, 2018.

S. Reinboldt, Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets, Platelets, vol.20, pp.441-444, 2009.

D. Steverding, The Cathepsin B-Selective Inhibitors CA-074 and CA-074Me Inactivate Cathepsin L Under Reducing Conditions The Open Enzyme Inhibition, Journal, vol.4, pp.11-16, 2011.

V. Turk and W. Bode, The cystatins: protein inhibitors of cysteine proteinases, FEBS Lett, vol.285, pp.213-219, 1991.

M. K. Houseweart, Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1), J Neurobiol, vol.56, pp.315-327, 2003.

B. Jones, P. J. Roberts, W. A. Faubion, E. Kominami, and G. J. Gores, Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line, Am J Physiol, vol.275, pp.723-730, 1998.

M. Di-michele, Functional studies and proteomics in platelets and fibroblasts reveal a lysosomal defect with increased cathepsin-dependent apoptosis in ATP1A3 defective alternating hemiplegia of childhood, J Proteomics, vol.86, pp.53-69, 2013.

I. Abd-elrahman, Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin, Cell Death Dis, vol.4, 2013.

W. H. Tang, Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets, Circulation, vol.129, pp.1598-1609, 2014.

O. Rasanen, M. Jarvinen, and A. Rinne, Localization of the human SH-protease inhibitor in the epidermis. Immunofluorescent studies, Acta Histochem, vol.63, pp.80025-80032, 1978.

D. C. Blaydon, Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion, Am J Hum Genet, vol.89, pp.564-571, 2011.

T. J. Eide, M. Jarvinen, V. K. Hopsu-havu, J. Maltau, and A. Rinne, Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesions of the uterine cervix, Acta Histochem, vol.93, issue.11, pp.80215-80216, 1992.

W. Machleidt, Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes, Hoppe Seylers Z Physiol Chem, vol.364, pp.1481-1486, 1983.

M. E. Davies and A. J. Barrett, Immunolocalization of human cystatins in neutrophils and lymphocytes, Histochemistry, vol.80, pp.373-377, 1984.

J. M. Burkhart, The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways, Blood, vol.120, pp.73-82, 2012.

C. C. Calkins, M. Sameni, J. Koblinski, B. F. Sloane, and K. Moin, Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy, J Histochem Cytochem, vol.46, pp.745-751, 1998.

B. C. Victor, A. Anbalagan, M. M. Mohamed, B. F. Sloane, and D. Cavallo-medved, Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion, Breast Cancer Res, vol.13, 2011.

H. Hayashi, A. Tokuda, and K. Udaka, Biochemical study of cellular antigen-antibody reaction in tissue culture. I. Activation and release of a protease, J Exp Med, vol.112, pp.237-247, 1960.

D. Keppler, Towards novel anti-cancer strategies based on cystatin function, Cancer Lett, vol.235, pp.159-176, 2006.

Y. Kimura and K. Yokoi-hayashi, Polymorphonuclear leukocyte lysosomal proteases, cathepsins B and D affect the fibrinolytic system in human umbilical vein endothelial cells, Biochim Biophys Acta, vol.1310, pp.1-4, 1996.

H. Riess, Possible role of extracellularly released phagocyte proteinases in coagulation disorder during liver transplantation, Transplantation, vol.52, pp.482-484, 1991.

A. Gupta, Cell cycle-and cancer-associated gene networks activated by Dsg2: evidence of cystatin A deregulation and a potential role in cell-cell adhesion, PLoS One, vol.10, 2015.

M. M. Ouseph, Autophagy is induced upon platelet activation and is essential for hemostasis and thrombosis, Blood, vol.126, pp.1224-1233, 2015.

C. Dubois, L. Panicot-dubois, J. F. Gainor, B. C. Furie, and B. Furie, Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model, J Clin Invest, vol.117, pp.953-960, 2007.

C. Dubois, L. Panicot-dubois, G. Merrill-skoloff, B. Furie, and B. C. Furie, Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo, Blood, vol.107, pp.3902-3906, 2006.

M. Poggi, Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34 + progenitors, Haematologica, vol.102, pp.282-294, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01478143

C. Sanchez, Diet modulates endogenous thrombin generation, a biological estimate of thrombosis risk, independently of the metabolic status, Arterioscler Thromb Vasc Biol, vol.32, pp.2394-2404, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00776037

N. Padilla, Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans, Arterioscler Thromb Vasc Biol, vol.34, pp.2330-2337, 2014.

E. Prifti, J. D. Zucker, K. Clement, and C. Henegar, Interactional and functional centrality in transcriptional co-expression networks, Bioinformatics, vol.26, pp.3083-3089, 2010.

P. Saultier, Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features, Haematologica, vol.102, pp.1006-1016, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01600750

M. Canault, Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding, J Exp Med, vol.211, pp.1349-1362, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01478363

P. Raeven, Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP mice, J Thromb Haemost, vol.12, pp.958-969, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01754836

R. Darbousset, Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation, Blood, vol.120, pp.2133-2143, 2012.

R. Darbousset, P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice, Blood, vol.124, pp.2575-2585, 2014.